Tag : VENCLEXTA

Latest News

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Newsemia
Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva®...
Latest News

FDA expands label for VENCLEXTA to include information about patients with previously-treated CLL

Newsemia
AbbVie, a research-based global biopharmaceutical company, today announced the U.S. Food and Drug Administration has expanded the label for VENCLEXTA® in combination with rituximab to...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World